ExsE, a Secreted Regulator of Type III Secretion Genes in Pseudomonas Aeruginosa

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2005 May 25

PMID 15911752

Citations 229

Authors

Arne Rietsch

Isabelle Vallet-Gely

Simon L Dove

John J Mekalanos

Affiliations

Soon will be listed here.

Abstract

Type III secretion systems are toxin delivery systems that are present in a large number of pathogens. A hallmark of all type III secretion systems studied to date is that expression of one or more of their components is induced upon cell contact. It has been proposed that this induction is controlled by a negative regulator that is itself secreted by means of the type III secretion machinery. Although candidate proteins for this negative regulator have been proposed in a number of systems, for the most part, a direct demonstration of their role in regulation is lacking. Here, we report the discovery of ExsE, a negative regulator of type III secretion gene expression in Pseudomonas aeruginosa. Deletion of exsE deregulates expression of the type III secretion genes. We provide evidence that ExsE is itself secreted by means of the type III secretion machinery and physically interacts with ExsC, a positive regulator of the type III secretion regulon. Taken together, these data demonstrate that ExsE is the secreted negative regulator that couples triggering of the type III secretion machinery to induction of the type III secretion genes.

Citing Articles

Pseudomonads coordinate innate defense against viruses and bacteria with a single regulatory system.

Brinkley D, Bertolli S, Gallagher L, Tan Y, de Silva M, Brockman A bioRxiv. 2025; .

PMID: 40060533 PMC: 11888443. DOI: 10.1101/2025.02.26.640152.

Cross-membrane cooperation among bacteria can facilitate intracellular pathogenesis.

Schator D, Kumar N, Chong S, Jung T, Jedel E, Smith B bioRxiv. 2025; .

PMID: 39975129 PMC: 11839010. DOI: 10.1101/2025.02.09.637186.

The T3SS can contribute to traversal of an epithelial multilayer independently of the T3SS needle.

Jedel E, Schator D, Kumar N, Sullivan A, Rietsch A, Evans D bioRxiv. 2025; .

PMID: 39975055 PMC: 11838347. DOI: 10.1101/2025.01.28.635263.

A conserved chaperone protein is required for the formation of a noncanonical type VI secretion system spike tip complex.

Sachar K, Kanarek K, Colautti J, Kim Y, Bosis E, Prehna G J Biol Chem. 2025; 301(3):108242.

PMID: 39880087 PMC: 11883445. DOI: 10.1016/j.jbc.2025.108242.

Multidrug efflux pumps of show selectivity for their natural substrates.

Mazza L, Bory A, Luscher A, Kloehn J, Wolfender J, Van Delden C Front Microbiol. 2025; 15():1512472.

PMID: 39850140 PMC: 11754269. DOI: 10.3389/fmicb.2024.1512472.

References

Warrens A, Jones M, Lechler R . Splicing by overlap extension by PCR using asymmetric amplification: an improved technique for the generation of hybrid proteins of immunological interest. Gene. 1997; 186(1):29-35. DOI: 10.1016/s0378-1119(96)00674-9. View

Anderson D, Ramamurthi K, Tam C, Schneewind O . YopD and LcrH regulate expression of Yersinia enterocolitica YopQ by a posttranscriptional mechanism and bind to yopQ RNA. J Bacteriol. 2002; 184(5):1287-95. PMC: 134855. DOI: 10.1128/JB.184.5.1287-1295.2002. View

Miller V . Connections between transcriptional regulation and type III secretion?. Curr Opin Microbiol. 2002; 5(2):211-5. DOI: 10.1016/s1369-5274(02)00303-x. View

Hancock R, Speert D . Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment. Drug Resist Updat. 2001; 3(4):247-255. DOI: 10.1054/drup.2000.0152. View

Velasco E, Thuler L, Martins C, Dias L, Goncalves V . Nosocomial infections in an oncology intensive care unit. Am J Infect Control. 1998; 25(6):458-62. DOI: 10.1016/s0196-6553(97)90067-5. View

Takeya K, Amako K . A rod-shaped Pseudomonas phage. Virology. 1966; 28(1):163-5. DOI: 10.1016/0042-6822(66)90317-5. View

Sundin C, Thelaus J, Broms J, Forsberg A . Polarisation of type III translocation by Pseudomonas aeruginosa requires PcrG, PcrV and PopN. Microb Pathog. 2004; 37(6):313-22. DOI: 10.1016/j.micpath.2004.10.005. View

Cambronne E, Sorg J, Schneewind O . Binding of SycH chaperone to YscM1 and YscM2 activates effector yop expression in Yersinia enterocolitica. J Bacteriol. 2004; 186(3):829-41. PMC: 321491. DOI: 10.1128/JB.186.3.829-841.2004. View

Goranson J, Zhu L, Sawa T, Wiener-Kronish J, Fleiszig S, Wu C . ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury. Mol Microbiol. 1997; 25(3):547-57. DOI: 10.1046/j.1365-2958.1997.4891851.x. View

10.

Carratala J, Roson B, Fernandez-Sevilla A, Alcaide F, Gudiol F . Bacteremic pneumonia in neutropenic patients with cancer: causes, empirical antibiotic therapy, and outcome. Arch Intern Med. 1998; 158(8):868-72. DOI: 10.1001/archinte.158.8.868. View

11.

Furste J, Pansegrau W, Frank R, Blocker H, Scholz P, Bagdasarian M . Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector. Gene. 1986; 48(1):119-31. DOI: 10.1016/0378-1119(86)90358-6. View

12.

Sato H, Frank D, Hillard C, Feix J, Pankhaniya R, Moriyama K . The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU. EMBO J. 2003; 22(12):2959-69. PMC: 162142. DOI: 10.1093/emboj/cdg290. View

13.

Dasgupta N, Lykken G, Wolfgang M, Yahr T . A novel anti-anti-activator mechanism regulates expression of the Pseudomonas aeruginosa type III secretion system. Mol Microbiol. 2004; 53(1):297-308. DOI: 10.1111/j.1365-2958.2004.04128.x. View

14.

Mavris M, Page A, Tournebize R, Demers B, Sansonetti P, Parsot C . Regulation of transcription by the activity of the Shigella flexneri type III secretion apparatus. Mol Microbiol. 2002; 43(6):1543-53. DOI: 10.1046/j.1365-2958.2002.02836.x. View

15.

Campana S, Taccetti G, Ravenni N, Masi I, Audino S, Sisi B . Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center. J Cyst Fibros. 2004; 3(3):159-63. DOI: 10.1016/j.jcf.2004.03.010. View

16.

Frank D . The exoenzyme S regulon of Pseudomonas aeruginosa. Mol Microbiol. 1998; 26(4):621-9. DOI: 10.1046/j.1365-2958.1997.6251991.x. View

17.

Ha U, Kim J, Badrane H, Jia J, Baker H, Wu D . An in vivo inducible gene of Pseudomonas aeruginosa encodes an anti-ExsA to suppress the type III secretion system. Mol Microbiol. 2004; 54(2):307-20. DOI: 10.1111/j.1365-2958.2004.04282.x. View

18.

Goure J, Pastor A, Faudry E, Chabert J, Dessen A, Attree I . The V antigen of Pseudomonas aeruginosa is required for assembly of the functional PopB/PopD translocation pore in host cell membranes. Infect Immun. 2004; 72(8):4741-50. PMC: 470589. DOI: 10.1128/IAI.72.8.4741-4750.2004. View

19.

Yahr T, Hovey A, Kulich S, Frank D . Transcriptional analysis of the Pseudomonas aeruginosa exoenzyme S structural gene. J Bacteriol. 1995; 177(5):1169-78. PMC: 176720. DOI: 10.1128/jb.177.5.1169-1178.1995. View

20.

Wick M, Frank D, Storey D, Iglewski B . Structure, function, and regulation of Pseudomonas aeruginosa exotoxin A. Annu Rev Microbiol. 1990; 44:335-63. DOI: 10.1146/annurev.mi.44.100190.002003. View